SNRS- Sunrise Technologies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies

SNRS 0.000001000

0.0%

Jun 6 11:01 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: majormember who wrote (1476)	8/14/1998 8:52:00 PM
From: bob glass	Read Replies (3) of 4140

Skane, Pam's friend made a typo. The article I referred to is titled "Holmium Laser Offers Opportunities for Mild Hyperopia, Presbyopia" "Phase 3 Trials indicate HTLK shows promise..." The article mentioned the phase 2 results at the Hunkeler Eye Center in Kansas City MO. "HLTK has its disadvantages, as well. First, the procedure is still in its infancy and is investigational. Long term follow-up is not yet available. Additionally, the procedure is limited to low levels of hyperopia ...Finally, the procedure does not correct for astigmatism..." I am a firm believer in refractive surgery. I actively promote it. This sounds to me like another tool, but I don't see a bombshell here. Just MHO. Regards, BG

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next